TrumpRx, the government website designed to offer lower-cost options for select brand-name prescriptions, officially launched on Feb. 5, according to President Donald Trump. The direct-to-consumer service is part of the administration’s efforts to reduce prescription costs in the United States.
Rather than selling medications directly, TrumpRx connects patients with manufacturer-sponsored discounts or coupons redeemable at participating pharmacies. The platform is intended to help patients facing high out-of-pocket costs for medications not fully covered by their insurance plans.
U.S. prescription drug prices are two to three times higher on average than those in other developed nations, and up to 10 times higher in some countries, according to a RAND Corporation report.
You May Also Like
According to the White House.gov, TrumpRx significantly reduces the prices of several high-cost medications, including GLP-1 therapies and fertility treatments.
Some of the listed discounts include:
- Wegovy for weight management: Starting at $149 per month, down from $1,349
- Ozempic for diabetes and weight management: Starting at $199 per month, down from $1,028
- Gonal-F injection for infertility: Starting at $168, down from $966
- Ovidrel injection for infertility: Starting at $84, down from $251
During a White House event, the president said millions of Americans could save money through the platform.
You May Also Like
“You’re going to save a fortune, and this is also so good for overall healthcare,” Trump said while unveiling the website, CNBC reported.
Before the launch, 16 pharmaceutical companies neg
otiated with the Trump administration to participate and offer certain prescription drugs at a discount to Medicaid patients.
At launch, the website only features medications from the first five participating manufacturers: AstraZeneca, Eli Lilly, Serono, Novo Nordisk, and Pfizer. Additional drugmakers are expected to be added in the coming months.
